Arcoxia (Organon / Merck & Co.) Etoricoxib Tablets – Advanced Selective COX-2 Inhibitor

### Description
Arcoxia is a premier prescription-strength nonsteroidal anti-inflammatory drug (NSAID) manufactured by Organon / Merck & Co. Featuring Etoricoxib as its active ingredient, it acts as a highly selective inhibitor of the cyclooxygenase-2 (COX-2) enzyme. By selectively targeting COX-2 pathways responsible for inflammation and pain while sparing COX-1 gastric mucosal protection mechanisms, it offers powerful relief from joint swelling, morning stiffness, acute gout attacks, and post-operative dental pain with minimized gastrointestinal disruption compared to traditional NSAIDs.

### Key Features & Benefits
* Selective COX-2 Inhibition: Specifically targets inflammation pathways while protecting standard gastric lining functions.
* 24-Hour Relief: Long-acting formulation designed to provide steady, all-day comfort with a single daily dose.
* Trusted Manufacturer: Produced under rigorous global pharmaceutical standards by Organon and Merck & Co.
* Rapid Onset: Quickly absorbed to alleviate acute pain flare-ups and chronic rheumatic discomfort effectively.

### How to Use
1. Storage: Store at room temperature below 30°C in a dry place, away from direct sunlight and moisture. Keep securely out of reach of children.
2. Preparation: Verify blister pack integrity and select the precise milligram strength prescribed for your specific condition.
3. Administration: Take orally with a full glass of water. Can be taken with or without food, though onset may be faster when taken on an empty stomach. Do not exceed recommended dosages.
4. Disposal: Safely discard any expired medication or empty blister sheets according to local pharmaceutical disposal guidelines.